Results 131 to 140 of about 48,453 (241)

Compared to PMLIII, PMLIV has a higher anti-VSV activity.

open access: yes, 2014
(A) U373MG-EV, U373MG-PMLIII or U373MG-PMLIV cells were not infected (-) or infected with VSV at MOIs of 0.2 or 1 for 8 h. Cell extracts were analyzed by Western blotting and revealed by anti-VSV and anti-Actin antibodies.
Mounira K. Chelbi-Alix (136150)   +5 more
core   +1 more source

Transcriptome analysis of long non-coding RNA and mRNA Profiles in VSV-infected BHK-21 Cells

open access: yesBMC Genomics
Background Vesicular stomatitis virus (VSV) is a typical non-segmented negative-sense RNA virus of the genus Vesiculovirus in the family Rhabdoviridae. VSV can infect a wide range of animals, including humans, with oral blister epithelial lesions. VSV is
Wuweiyi Han   +12 more
doaj   +1 more source

Extracellular Vesicle‐Associated IL4 Displays Enhanced Anti‐Inflammatory Properties in Microglial Cells

open access: yesJournal of Extracellular Biology, Volume 5, Issue 6, June 2026.
ABSTRACT Neuroinflammation and neurodegeneration are strictly related phenomena, characterized by dysregulation of microglia, central nervous system (CNS) resident immune cells. Interleukin‐4 (IL4) has shown beneficial abilities to re‐establish microglial homeostasis in experimental models of CNS traumatic injury, stroke and multiple sclerosis, but its
Giulia Marostica   +11 more
wiley   +1 more source

VSV-Epidemic-2023

open access: yes
Data and supporting information for publication describing epidemic analysis of Vesicular stomatitis (VSV) outbreak in California, USA in ...
John M Humphreys
core  

VSV replication in Lutzomyia cell lines.

open access: yes, 2018
(A) Kinetics of VSV replication in LL5 cell using a MOI of 10 PFU/mL. Statistical significance was determined using Tukey’s Multiple Comparison test between infected groups at different times post infection.
Maurício Roberto Viana Sant'Anna (5334974)   +9 more
core   +1 more source

Broadly Protective Antibody‐Like Vaccines Against Highly Pathogenic Coronaviruses

open access: yesJournal of Medical Virology, Volume 98, Issue 6, June 2026.
ABSTRACT SARS‐CoV‐2 and MERS‐CoV are highly pathogenic and contagious coronaviruses. Despite intensive vaccination, SARS‐CoV‐2 continues to spread, and no FDA‐approved vaccines exist for MERS‐CoV; thus, more effective and safer vaccine options are needed. The receptor‐binding domain (RBD) of coronaviruses is a primary target of neutralizing antibodies (
Assala Helal   +20 more
wiley   +1 more source

The Expanding Landscape of Microbiota Medicine: Indications, Therapeutic Modalities, and the Path Towards Integrative Microbiome‐Targeting Healthcare

open access: yesMicrobiota Medicine Research, Volume 1, Issue 2, Page 63-89, June 2026.
ABSTRACT The growing recognition of the microbiome’s role in human health has propelled the emergence of microbiota medicine—a new discipline integrating microbiology, multi‐omics, and clinical science. Advances in sequencing, data integration, and interventions such as fecal microbiota transplantation (FMT) have transitioned the field from ...
Min Dai   +6 more
wiley   +1 more source

A Method for the Production of Recombinant VSVs with Confirmation of Biological Activity

open access: yesActa Naturae
The design of new effective cancer treatment methods is a promising and important research field in translational medicine. Oncolytic viruses can induce immunogenic cell death by activating the body’s immune system to recognize tumor cells. This work presents the results for optimizing the production of recombinant vesicular stomatitis viruses (rVSVs).
Moroz, V. D.   +9 more
openaire   +2 more sources

IFN-β and ISG mRNA expression in neurotropic VSV infection.

open access: yes, 2014
Mice were infected intranasally with 5×106 pfu of VSV or VSV-eGFP. A, Expression level of IFN-β in different brain parts was determined by real-time RT-PCR, A, IFN-β.
Sharmila Nair (544281)   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy